GlobalData on MSN11h
Menarini to enhance BPDCN detection with VisualDx’s link
The Menarini Group, along with its subsidiary Stemline Therapeutics, has announced a partnership with VisualDx to enhance the ...
Medscape1d
Skin Cancer Outcomes Worsen With Rise in Risk Factors
The greater the number of risk factors in patients with cutaneous squamous cell carcinoma, the higher the likelihood of poor ...
Managed Healthcare Executive11d
Melanoma Treatment Advances Now Crossing into Other Skin Cancers
Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with ...
Earth.com6d
Skin cancer risk: The hidden factors beyond sunburn
Skin cancer stands as the most frequently diagnosed cancer in the United States, bringing about millions of cases annually.
Menarini Group Announces Collaboration with VisualDx to Aid in Identifying People Who May Have Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused ...
The scaly sign that could be a sign of deadly skin cancer
Squamous cell carcinoma is the second most common type of skin cancer, and can be deadly if left untreated. Here are the ...